| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.80▼ | 1.80▼ | 1.79▼ | 1.81▼ | 2.23▼ |
| MA10 | 1.83▼ | 1.83▼ | 1.84▼ | 1.89▼ | 1.64▲ |
| MA20 | 1.87▼ | 1.84▼ | 1.84▼ | 2.31▼ | 0.98▲ |
| MA50 | 1.88▼ | 2.10▼ | 2.21▼ | 1.30▲ | 0.91▲ |
| MA100 | 2.26▼ | 1.73▲ | 1.49▲ | 0.82▲ | 1.97▼ |
| MA200 | 1.26▲ | 0.94▲ | 0.83▲ | 0.70▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | 0.007▲ | 0.007▲ | -0.149▼ | 0.167▲ |
| RSI | 42.895▼ | 42.416▼ | 41.509▼ | 44.512▼ | 54.156▲ |
| STOCH | 31.808 | 23.884 | 24.198 | 14.149▼ | 54.440 |
| WILL %R | -66.667 | -72.727 | -71.111 | -99.056▼ | -66.725 |
| CCI | -80.270 | -85.474 | -64.970 | -98.552 | 34.408 |
|
Monday, November 09, 2026 09:03 PM
Medicus Pharma Ltd (MDCX) outlined its CD228V license from Pfizer, a proposed $135 million SkinJet SPAC combination and a $35.9 million nine-month net loss amid tight liquidity.
|
|
Monday, November 09, 2026 04:00 PM
Medicus Pharma Ltd ( ) has issued an announcement. Medicus Pharma is a precision-guided biotechnology and life-sciences company developing novel therapeutic assets, with a focus o ...
|
|
Monday, November 09, 2026 08:30 AM
Capital efficiency strategy prioritizes CD228V development while seeking separate public listing for SkinJect® and ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/11/26 | 1.80 | 1.8527 | 1.63 | 1.64 | 53,576 |
| 10/11/26 | 1.92 | 2.10 | 1.72 | 1.83 | 87,456 |
| 09/11/26 | 1.87 | 2.1648 | 1.7891 | 1.885 | 61,925 |
| 06/11/26 | 1.88 | 2.00 | 1.81 | 1.87 | 30,350 |
| 05/11/26 | 1.85 | 1.9056 | 1.70 | 1.83 | 43,407 |
| 04/11/26 | 2.12 | 2.156 | 1.71 | 1.88 | 234,281 |
| 03/11/26 | 1.95 | 2.12 | 1.90 | 2.03 | 25,999 |
| 02/11/26 | 1.86 | 1.982 | 1.78 | 1.93 | 31,231 |
| 30/10/26 | 2.17 | 2.1799 | 1.82 | 1.88 | 86,699 |
| 29/10/26 | 2.48 | 2.48 | 2.1246 | 2.15 | 123,405 |
|
|
||||
|
|
||||
|
|